These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 30806580)
21. Deciphering the crucial molecular properties of a series of Benzothiazole Hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein. Marimuthu P; Balasubramanian PK; Singaravelu K J Biomol Struct Dyn; 2018 Aug; 36(10):2654-2667. PubMed ID: 28793831 [TBL] [Abstract][Full Text] [Related]
22. Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors. Shah BM; Modi P; Trivedi P J Biomol Struct Dyn; 2021 Apr; 39(6):2021-2043. PubMed ID: 32242496 [TBL] [Abstract][Full Text] [Related]
23. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models. Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122 [TBL] [Abstract][Full Text] [Related]
24. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification. Islam MA; Pillay TS J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527 [TBL] [Abstract][Full Text] [Related]
25. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches. Jana S; Singh SK J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408 [TBL] [Abstract][Full Text] [Related]
26. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer. Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730 [TBL] [Abstract][Full Text] [Related]
27. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations. Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912 [TBL] [Abstract][Full Text] [Related]
28. Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation. Raafat A; Mowafy S; Abouseri SM; Fouad MA; Farag NA Comput Biol Med; 2022 Jul; 146():105526. PubMed ID: 35487125 [TBL] [Abstract][Full Text] [Related]
29. High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods. Faris A; Ibrahim IM; Hadni H; Elhallaoui M J Biomol Struct Dyn; 2024 Sep; 42(14):7574-7599. PubMed ID: 37539779 [TBL] [Abstract][Full Text] [Related]
30. Pharmacophore modeling, 3D-QSAR and docking study of 2-phenylpyrimidine analogues as selective PDE4B inhibitors. Tripuraneni NS; Azam MA J Theor Biol; 2016 Apr; 394():117-126. PubMed ID: 26804643 [TBL] [Abstract][Full Text] [Related]
31. Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents. Patel P; Singh A; Patel VK; Jain DK; Veerasamy R; Rajak H Comb Chem High Throughput Screen; 2016; 19(9):735-751. PubMed ID: 27487787 [TBL] [Abstract][Full Text] [Related]
32. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors. Azam MA; Thathan J SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673 [TBL] [Abstract][Full Text] [Related]
33. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents. Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326 [TBL] [Abstract][Full Text] [Related]
34. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles. Yu CX; Tan JW; Rullah K; Imran S; Tham CL J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457 [TBL] [Abstract][Full Text] [Related]
35. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches. Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153 [TBL] [Abstract][Full Text] [Related]
36. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors. Reddy KK; Singh SK Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351 [TBL] [Abstract][Full Text] [Related]
37. Combined molecular modelling and 3D-QSAR study for understanding the inhibition of NQO1 by heterocyclic quinone derivatives. López-Lira C; Alzate-Morales JH; Paulino M; Mella-Raipán J; Salas CO; Tapia RA; Soto-Delgado J Chem Biol Drug Des; 2018 Jan; 91(1):29-38. PubMed ID: 28643389 [TBL] [Abstract][Full Text] [Related]
38. Screening of inhibitors as potential remedial against Ebolavirus infection: pharmacophore-based approach. Sankar M; K L; Jeyachandran S; Pandi B J Biomol Struct Dyn; 2021 Feb; 39(2):395-408. PubMed ID: 31928158 [TBL] [Abstract][Full Text] [Related]
39. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors. Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680 [TBL] [Abstract][Full Text] [Related]
40. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7. Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]